Credit rating agency, CARE has assigned ‘AA (Stable)/ A1+’ rating to Ipca Laboratories’ long-term/short-term bank facilities worth Rs 1190 crore. The ratings assigned to the bank facilities of Ipca Laboratories (Ipca) derive strength from the proven track record of more than six decades and experienced promoters, global presence and dominant market position in anti-malarial and pain management drugs in the domestic pharmaceutical industry, strong and diversified product portfolio with backward integrated and diversified operations.
The ratings also positively factor the continuous product development in terms of Research & Development and improvement in operational performance during 9MFY17. Ipca has also consistently exhibited a strong financial risk profile with comfortable capital structure and liquidity profile.
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1850.40 |
| Dr. Reddys Lab | 1310.50 |
| Cipla | 1365.25 |
| Zydus Lifesciences | 940.00 |
| Lupin | 2442.35 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: